NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Insitro

Insitro

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.insitro.com/

Last Round

Series C

Mar 15, 2021

Est. Valuation

$2.57B

Total Funding Raised

$743M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Insitro is a biotechnology company that leverages machine learning and high-throughput biology to accelerate drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

drug discoveryAI drug discoverybiotech AIprecision medicinetherapeutic target discoverydisease modelingin silico drug discoverymultimodal data analysishigh-throughput biologypharmaceutical R&Dcausal AIMASHALSbiotech platformAI-powered pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Insitro Comparables

Compare Insitro with similar companies based on industry and business-model similarity.

Insitro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Valo Health
91%
Xaira Therapeutics
91%
Insilico Medicine
87%

Insitro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 15, 2021
Series BMay 26, 2020
Series AApr 16, 2019
Series AMay 1, 2018

Key People

Founding team and executive leadership

Daphne Koller

Founder And CEO

Founding Team

Insitro Investors

Notable investors and investment history

Insitro investors
InvestorRounds
Andreessen HorowitzSeries A, Series C, Series B
Human CapitalSeries C
CPP InvestmentsSeries B, Series C
SoftBank Investment AdvisersSeries C
TemasekSeries C
GVSeries A, Series B, Series C
ARCH Venture PartnersSeries B, Series C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2026

    $10 million received from Bristol Myers Squibb collaboration.

  • Mar 23, 2026

    Launched Virtual Human, a genetically anchored causal AI engine for disease research.

Insitro Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Insitro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Insitro's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range255
Year Founded2018
Last FundingMar 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.